MARKET

DHR

DHR

Danaher Corporation
NYSE
250.65
+2.88
+1.16%
After Hours: 250.54 -0.11 -0.04% 17:03 02/21 EST
OPEN
246.31
PREV CLOSE
247.77
HIGH
250.75
LOW
246.06
VOLUME
1.55M
TURNOVER
0
52 WEEK HIGH
269.00
52 WEEK LOW
181.90
MARKET CAP
185.28B
P/E (TTM)
39.27
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at DHR last week (0212-0216)?
Weekly Report · 2d ago
Noteworthy ETF Outflows: IWV, AMGN, DHR, PFE
NASDAQ · 02/14 15:51
Walter Lohr Jr. Retires from Danaher Board of Directors
TipRanks · 02/14 13:32
Tracking Akre Capital Management Portfolio - Q4 2023 Update
Akre Capital Management's 13F portfolio value increased by 4% to $11.88B, with 18 positions in total. The largest stakes in the portfolio are Mastercard, Moody's, American Tower, KKR, and O'Reilly Automotive. The fund's annualized returns are 14.88% compared to the S&P 500 Index.
Seeking Alpha · 02/12 11:33
Weekly Report: what happened at DHR last week (0205-0209)?
Weekly Report · 02/12 09:01
Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings
Danaher Corporation has a price-to-earnings ratio of 42.8x compared to the market. The company's earnings have been falling quicker than most other companies in recent years. Its high P/E ratio is higher than most companies in the U.S. With a similar earnings growth outlook. However, the company is expected to grow earnings by 12% over the next three years.
Simply Wall St · 02/10 12:59
ITT Q4 Earnings In Line With Estimates, Revenues Increase Y/Y
NASDAQ · 02/09 16:01
Carlisle (CSL) Q4 Earnings Beat Estimates, Revenues Decline Y/Y
NASDAQ · 02/07 15:18
More
About DHR
Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services that are used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. Its Life Sciences segment offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites, and cells. The Life Sciences segment also offers antibodies, reagents, biomarkers, and assays through Abcam plc (Abcam). Its Diagnostics segment offers clinical instruments, reagents, consumables, software that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease.

Webull offers Danaher Corp stock information, including NYSE: DHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DHR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DHR stock methods without spending real money on the virtual paper trading platform.